The point of care (POC) molecular diagnostics market is expected to grow at a CAGR of 13% from 2019 to 2027 to reach at $2.32 billion by 2027. Molecular diagnostics has been conducted in the centralized laboratories since many years; however, its few drawbacks like delay in results, high cost of tests, less accuracy, and late disease diagnosis are leading to increase in mortality rate, thereby hindering the growth of this market. Thus, to overcome this, the new field named as point of care molecular diagnostics has emerged. Its ability to provide rapid and accurate results in less than 1-2 hours has helped to increase its adoption in various low-resource settings. The factors such as rising prevalence of chronic diseases, development of CLIA-Waived molecular POC tests, venture capital funding for development of POC molecular diagnostics products, growing demand for POC molecular diagnostics, and rapid decision making in emergency care are expected to propel the growth in the global POC molecular diagnostics market.
Rising Prevalence of Chronic Diseases Associated with Aging Population is Propelling the Growth of POC Molecular Diagnostics Market
As per the data from United Nations, the number of aged people is continuously increasing over the several decades. Such demographic shift is leading to increase in the prevalence of various chronic diseases. For instance, as per the International Journal of Cancer, the number of new cancer cases in the world was 14.1 million in 2012, which is expected to grow 24.4 million by 2035 with China showing the highest number of cancer cases among 65 years and older. This is attributed to the rising number of cancer risk factors, lack of information about their causes, and lack of detection & treatment solutions. Present diagnostic methods for cancer are invasive (for instance, cystoscopy – insertion of a hollow tube/cystoscope equipped with a lens into urethra to bladder for diagnosis of cancer). In such scenario, less invasive methods such as point of care molecular tests may prove effective.
Apart from cancer in aged people, respiratory diseases from small children to adults are becoming one of the top five diseases responsible for deaths. As per the National Institute of Allergy and Infectious Diseases, globally, Respiratory Syncytial Virus (RSV) affects around 64 million people and causes 160,000 deaths each year. Moreover, the WHO predicted that the global burden of RSV-associated acute lower respiratory infection is found to be 33 million annually, resulting in more than 3 million hospitalizations and 59,600 in-hospital deaths in children aged under 5 years. However, there is only 1 vaccine approved for prevention of RSV infections till 2016. There are many vaccines which are still under clinical trials. This increases the cases of death as people are not aware about the available treatment. Thus, the availability of POC molecular diagnostic tests plays an important role in quick analysis and thereby helps in offering immediate treatment to patients.
Click here to: Get Free Request Sample Pages of this report
Key Findings in the Global POC Molecular Diagnostics Market Study:
RT-qPCR Segment Dominated the POC Molecular Diagnostics Market in 2019
The factors such as large number of commercially available RT-qPCR based POC molecular diagnostic systems or tests compared to other technologies, use of RT-qPCR in proteomics & genomics, and need for rapid diagnosis of viral & infectious diseases are contributing to the largest share of this segment.
Kits & Assays Segment to Grow at the Fastest CAGR During the Forecast Period
Kits & Assays are essential components during any laboratory procedure. Its frequent use in the molecular diagnostic testing resulted into its higher volume and value share. Apart from this, growing prevalence of chronic diseases resulted into technological advancements by the key market players to expand their product portfolio of disease specific assays for early diagnosis. In addition, growing focus of key market players on receiving CLIA approval further support the fastest growth of kits & assays segment.
Respiratory Diseases Held the Largest Share of the POC Molecular Diagnostics Market in 2019
The respiratory diseases segment dominated the POC molecular diagnostics market in 2019. The factors such as increasing number of respiratory & associated infectious diseases, large number of commercialized POC molecular diagnostic products for respiratory disease diagnosis, and focus of key market players on adopting various strategies for commercializing or developing advanced POC molecular diagnostic products contribute to the largest share of this application segment.
Asia Pacific: The Fastest Growing Market
At regional level, the overall POC molecular diagnostics market is dominated by North America in 2019, while, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of Asia Pacific POC molecular diagnostics market are rising incidences of chronic diseases associated with geriatric population, expansion of key market players in this region, insufficient sophisticated central laboratory testing services, and potential cost effectiveness of POC molecular diagnosis.
Key Players
The report includes competitive landscape based on the extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in the industry over the past 5 years. The key players profiled in the global POC molecular diagnostics market are Alere Inc. (U.S.), DxNA, LLC. (U.S.), Mesa Biotech Inc. (U.S.), Meridian Bioscience Inc. (U.S.), Danaher Corporation (U.S.), Quidel Corporation (U.S.), Biocartis Group NV (Belgium), bioMérieux SA (France), Thermo Fisher Scientific (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland).
Scope of the Report:
Market by Product & Solution
Market by Technology
Market by Application
Market by End User
Market by Geography
Key questions answered in the report-
Kits & Assays accounted for the largest share of the point of care molecular diagnostics market
Clinics and diagnostic laboratories accounted for the largest share of the point of care molecular diagnostics market
The point of care molecular diagnostics market favors both larger and local manufacturers that compete in multiple segments
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3 Executive Summary
4. Market insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases
4.2.2. Development of CLIA-Waived Molecular POC Tests
4.2.3. Venture Capital Funding for Development of POC Molecular Diagnostics Products
4.2.4. Lack of Skilled Professionals and Need for POC Molecular Diagnostics Testing in Low Resource Setting
4.2.5. Rapid Decision Making in Emergency Care
4.3. Restraints
4.3.1. Tedious Regulatory Approval Process
4.3.2. Pricing Pressures Owing to Reimbursement Cuts
4.4. Opportunity
4.4.1. Growing Opportunities from Emerging Countries
5. POC Molecular Diagnostics Market, by Product
5.1. Introduction
5.2. Kits & Assays
5.3. Analyzers/Instruments
5.4. Software and Services
6. POC Molecular Diagnostics Market, by Technology
6.1. Introduction
6.2. Real-Time Quantitative Polymerase Chain Reaction (Rt-QPCR)
6.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4. Other Technologies
7. POC Molecular Diagnostics Market, by Application
7.1. Introduction
7.2. Respiratory Diseases
7.3. Sexually Transmitted Diseases (STDs)
7.4. Hospital Acquired infections (HAIs)
7.5. Cancer/Oncology
7.6. Prenatal/Neonatal Testing
7.7. Other Applications
8. POC Molecular Diagnostics Market, by End User
8.1. Introduction
8.2. Clinics and Diagnostics Laboratories
8.3. Hospital Outpatient Departments & ICUs
8.4. Research and Academic institute
9. POC Molecular Diagnostics Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis
11. Company Profiles
11.1. Abbott Laboratories (Including Alere)
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Quidel Corporation
11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. F. Hoffmann-La Roche Ltd
11.3.1. Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Strategic Developments
11.4. Danaher Corporation
11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Thermo Fisher Scientific Inc.
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Strategic Developments
11.6. Biomérieux SA
11.6.1. Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Strategic Developments
11.7. Meridian Bioscience Inc.
11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Strategic Developments
11.8. Mesa Biotech Inc.
11.8.1. Business Overview
11.8.2. Product Portfolio
11.8.3. Strategic Developments
11.9. DxNa, LLC.
11.9.1. Business Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Biocartis Group NV
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global POC Molecular Diagnostics Market: Impact Analysis of Market Drivers (2019–2027)
Table 2 Global Number of New Cancer Cases Among 65 Years and Older (In Millions)
Table 3 Who Prevalence of Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis, by Region (In %)
Table 4 Some POC Molecular Diagnostic Products with CLIA Waiver
Table 5 Global POC Molecular Diagnostics Market: Impact Analysis of Market Restraints (2019–2027)
Table 6 Global POC Molecular Diagnostics Market Size, by Product, 2017-2027 ($Million)
Table 7 POC Molecular Diagnostic Kits & Assays Prices
Table 8 Commercialized POC Molecular Diagnostic Kits & Assays
Table 9 POC Molecular Diagnostic Kits & Assays Under Development
Table 10 Recent Strategic Developments for Kits & Assays
Table 11 Global POC Molecular Diagnostic Kits & Assays Market Size, by Country/Region, 2017-2027 ($Million)
Table 12 Key Companies offering POC Molecular Diagnostic Analyzers/Instruments
Table 13 Cost of POC Molecular Diagnostic Analyzers/Instruments
Table 14 Global POC Molecular Diagnostics Analyzers/Instruments Market Size, by Country/Region, 2017-2027 ($Million)
Table 15 Key Companies Providing POC Molecular Diagnostic Software/Services
Table 16 Global POC Molecular Diagnostics Software and Services Market Size, by Country/Region, 2017-2027 ($Million)
Table 17 Global POC Molecular Diagnostics Market Size, by Technology, 2017-2027 ($Million)
Table 18 Key Companies offering RT-qPCR Based POC Molecular Diagnostic Products
Table 19 Comparison of RT-qPCR and Isothermal Technology
Table 20 Global RT-qPCR Based POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 21 Key Companies offering INAAT Based POC Mdx Products
Table 22 Global INAAT Based POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 23 Global Other Technologies Based POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 24 Global POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 25 Commercialized POC Molecular Diagnostic Products for Respiratory Diseases
Table 26 Recent Strategic Developments for Respiratory Disease Diagnosis
Table 27 Global POC Molecular Diagnostic Market Size for Respiratory Diseases, by Country/Region, 2017-2027 ($Million)
Table 28 Commercialized POC Molecular Diagnostic Products for Sexually Transmitted Diseases (STDs)
Table 29 POC Molecular Diagnostic Products for Sexually Transmitted Diseases (STDs) Under Development
Table 30 Global POC Molecular Diagnostics Market Size for Sexually Transmitted Diseases (STDs), by Country/Region, 2017-2027 ($Million)
Table 31 Commercialized POC Molecular Diagnostic Products for Healthcare-Associated Infections (HAIs)
Table 32 Global POC Molecular Diagnostics Market Size for Healthcare-Associated Infections (HAIs), by Country/Region, 2017-2027 ($Million)
Table 33 Commercialized POC Molecular Diagnostic Products for Cancer/Oncology
Table 34 Global POC Molecular Diagnostics Market Size for Cancer/Oncology, by Country/Region, 2017-2027 ($Million)
Table 35 Commercialized POC Molecular Diagnostic Products for Neonatal/Prenatal Testing
Table 36 Global POC Molecular Diagnostics Market Size for Prenatal/Neonatal Testing, by Country/Region, 2017-2027 ($Million)
Table 37 Commercialized POC Molecular Diagnostic Products for Other Applications
Table 38 Global POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 39 Global POC Molecular Diagnostics Market Size for Clinics and Diagnostic Laboratories, by Country/Region, 2017-2027 ($Million)
Table 40 Key Companies offering POC Molecular Diagnostic Products for Hospital Acquired infections
Table 41 Global POC Molecular Diagnostics Market Size for Hospital Outpatient Departments & ICU, by Country/Region, 2017-2027 ($Million)
Table 42 Global POC Molecular Diagnostics Market Size for Research & Academics institutes, by Country/Region, 2017-2027 ($Million)
Table 43 Global POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 44 North America: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Table 45 North America: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 46 North America: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 47 North America: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 48 North America: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 49 U.S.: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 50 U.S.: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 51 U.S.: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 52 U.S.: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 53 Canada: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 54 Canada: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 55 Canada: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 56 Canada: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 57 Europe: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Table 58 Europe: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 59 Europe: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 60 Europe: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 61 Europe: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 62 Germany: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 63 Germany: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 64 Germany: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 65 Germany: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 66 France: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 67 France: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 68 France: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 69 France: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 70 U.K.: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 71 U.K.: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 72 U.K.: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 73 U.K.: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 74 Italy: Cancer Prevalence Cases, 2010 and 2020
Table 75 Italy: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 76 Italy: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 77 Italy: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 78 Italy: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 79 Spain: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 80 Spain: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 81 Spain: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 82 Spain: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 83 RoE: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 84 RoE: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 85 RoE: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 86 RoE: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 87 Asia Pacific: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Table 88 Asia Pacific: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 89 Asia Pacific: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 90 Asia Pacific: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 91 Asia Pacific: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 92 Japan: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 93 Japan: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 94 Japan: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 95 Japan: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 96 China: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 97 China: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 98 China: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 99 China: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 100 India: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 101 India: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 102 India: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 103 India: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 104 RoAPAC: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 105 RoAPAC: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 106 RoAPAC: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 107 RoAPAC: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 108 Latin America: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 109 Latin America: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 110 Latin America: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 111 Latin America: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 112 Middle East & Africa: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 113 Middle East & Africa: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 114 Middle East & Africa: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 115 Middle East & Africa: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 116 Number of Developments by the Major Players During 2016-2020
Table of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 The Kits and Assays Segment Dominates the Global POC Molecular Diagnostics Market
Figure 8 Global POC Molecular Diagnostics Market Size, by Technology, 2019-2027 ($Million)
Figure 9 Global POC Molecular Diagnostics Market Size, by Application, 2019-2027 ($Million)
Figure 10 The Clinics & Diagnostic Laboratories Segment Will Dominate the Global POC Molecular Diagnostics Market during the forecast Period by 2025
Figure 11 Point of Care Molecular Diagnostics Market, by Region ($Million)
Figure 12 Market Dynamics
Figure 13 Global Geriatric Population, 1950-2020 (In Thousand)
Figure 14 Disposable Personal Income in China (In $)
Figure 15 Percent of Major Disease Groups to Total Disability-Adjusted Life Years (DALYs) in India, 1990 and 2016
Figure 16 Global POC Molecular Diagnostics Market Size, by Product, 2019-2027 ($Million)
Figure 17 Global POC Molecular Diagnostics Market Size, by Technology, 2019-2027 ($Million)
Figure 18 Global POC Molecular Diagnostics Market Size, by Application, 2019-2027 ($Million)
Figure 19 Global POC Molecular Diagnostics Market Size, by End User, 2019-2027 ($Million)
Figure 20 U.S. Distribution of Outpatient Vs. Inpatient Revenues, 1995 – 2016
Figure 21 Global POC Molecular Diagnostics Market Size, by Region, 2019-2027 ($Million)
Figure 22 North America: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Figure 23 U.S. Influenza Burden (2010-2018)
Figure 24 Canada: Chlamydia and Gonorrhea Infections Cases (2006-2017)
Figure 25 Europe: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Figure 26 Germany: VRE Infection Data for ICUs and Surgical Departments, by Infection Site, 2010-2016 (%)
Figure 27 France: Percentage of Older People (65 Years and Above), 2010-2050
Figure 28 Asia Pacific: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Figure 29 China Population Growth Chart
Figure 30 Key Growth Strategies Adopted by Leading Players -2016-2020
Figure 31 Point of Care Molecular Diagnostics: Competitive Benchmarking
Figure 32 Global Flow Cytometry Market Share, by Key Players, 2018 (%)
Figure 33 Abbott Laboratories: Financial Overview (2017-2018)
Figure 34 Quidel Corporation: Financial Overview (2016-2018)
Figure 35 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018)
Figure 36 Danaher Corporation: Financial Overview (2016-2018)
Figure 37 Thermo Fisher Scientific Inc..: Financial Overview (2016-2018)
Figure 38 Biomérieux SA: Financial Overview (2016-2018)
Figure 39 Meridian Bioscience Inc.: Financial Overview (2017-2019)
Figure 40 Biocartis Group NV: Financial Overview (2016-2018)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Nov-2022
Published Date: Oct-2022
Published Date: Oct-2022
Published Date: Oct-2022
